Domestic mutual funds (MFs) have taken a liking to pharmaceutical stocks, following a steep fall in the latter's prices.
While they expect the pharma sector to undergo headwinds, they are taking a contrary view on select stocks with an investment horizon of two to three years. Sun Pharmaceutical, Apollo Hospital Enterprise, Dr Reddy's Laboratories, Aurobindo Pharma and Fortis Healthcare were among the most-bought stocks in the month of May by fund managers. Last month, Divi's Laboratories, along with Aurobindo and Fortis Healthcare, were the top picks.
